The new study looked at one of these drugs, semaglutide, which is the drug in Ozempic and Wegovy
Similar investigations have been performed for subcutaneous treatment with tirzepatide, a combined glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist [29], as well as for the GLP-1RAs liraglutide, exenatide, dulaglutide, and semaglutide [30,31,32,33,34]
Dual agonists may offer incremental efficacy over pure GLP-1s, so Regenerons investment is betting on that next wave
It is unclear if semaglutide causes the same effect in humans
According to the Semaglutide Treatment Effect in People with Obesity (STEP) 1 study, once-weekly semaglutide combined with lifestyle management led to significant weight loss in obese people
Step 2: Online Consultation A licensed provider conducts an online evaluation based on your health background, weight loss intentions, and current medications to recommend a suitable course of treatment